Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study

<p><strong>Aims:</strong> Lethal arrhythmias in hypertrophic cardiomyopathy (HCM) are widely attributed to myocardial ischaemia and fibrosis. How these factors modulate arrhythmic risk remains largely unknown, especially as invasive mapping protocols are not routinely used in these...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Coleman, JA, Doste, R, Ashkir, Z, Coppini, R, Sachetto, R, Watkins, H, Raman, B, Bueno Orovio, A
Format:	Journal article
Język:	English
Wydane:	Oxford University Press 2024

Podobne zapisy

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
od: Coleman, JA, i wsp.
Wydane: (2023)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
od: Coleman, JA, i wsp.
Wydane: (2024)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
od: Doste, R, i wsp.
Wydane: (2022)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
od: James A. Coleman, i wsp.
Wydane: (2024-04-01)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
od: Coleman, J, i wsp.
Wydane: (2023)

Pharmacological management of hypertrophic cardiomyopathy: From bench to bedside
od: Palandri, C, i wsp.
Wydane: (2022)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
od: Ariga, R, i wsp.
Wydane: (2019)

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy
od: Coleman, JA
Wydane: (2024)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
od: Passini, E, i wsp.
Wydane: (2015)

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
od: Margara, F, i wsp.
Wydane: (2022)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
od: Raman, B, i wsp.
Wydane: (2017)

Non-invasive imaging of myocardial disarray associates with ventricular arrhythmia in hypertrophic cardiomyopathy
od: Ariga, R, i wsp.
Wydane: (2017)

Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
od: Darson Du, MD, i wsp.
Wydane: (2022-04-01)

Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy
od: Muthiah Subramanian, i wsp.
Wydane: (2024-01-01)

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
od: Francesca Margara, i wsp.
Wydane: (2022-12-01)

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
od: Coleman, J
Wydane: (2024)

A multi-scale computational investigation of cardiac electrophysiology and arrhythmias in acute ischaemia
od: Dutta, S
Wydane: (2014)

Sudden death in hypertrophic cardiomyopathy.
od: Watkins, H
Wydane: (2000)

Ventricular arrhythmias in apical hypertrophic cardiomyopathy: association with late gadolinium enhancement
od: Lopes Mário G, i wsp.
Wydane: (2010-01-01)

International Practice Patterns in the Detection and Management of Arrhythmias in Patients With Hypertrophic Cardiomyopathy
od: Matthew Cheung, i wsp.
Wydane: (2022-10-01)

Ventricular Arrhythmias in Hypertrophic Cardiomyopathy- Can We Ever Predict Them?
od: Narayanan Namboodiri, i wsp.
Wydane: (2010-03-01)

Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience
od: Christian Steinberg, i wsp.
Wydane: (2020-10-01)

Myocardial dysfunction in hypertrophic cardiomyopathy.
od: Ashrafian, H, i wsp.
Wydane: (2001)

Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study
od: Lyon, A, i wsp.
Wydane: (2019)

Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
od: Hua Shen, i wsp.
Wydane: (2022-08-01)

Burden and trends of arrhythmias in hypertrophic cardiomyopathy and its impact of mortality and resource utilization
od: Byomesh Tripathi, i wsp.
Wydane: (2019-08-01)

Multiscale modelling of β-adrenergic stimulation in cardiac electromechanical function
od: Doste, R, i wsp.
Wydane: (2021)

Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. Purkinje-myocardial coupling abnormalities
od: Lyon, A, i wsp.
Wydane: (2018)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
od: Ashrafian, H, i wsp.
Wydane: (2005)

Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis
od: Ashkir, Z, i wsp.
Wydane: (2023)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
od: Hudsmith, L, i wsp.
Wydane: (2006)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study
od: Coppini, R, i wsp.
Wydane: (2019)

INFLUENCE OF THE POLYMORPHISM OF THE RENIN-ANGIOTENSIN SYSTEM GENES ON THE CARDIAC ARRHYTHMIAS IN CHILDREN WITH HYPERTROPHIC CARDIOMYOPATHY
od: N. A. Berezneva, i wsp.
Wydane: (2013-05-01)

High‐Resolution ECG for Predicting Ventricular Arrhythmia in Hypertrophic Cardiomyopathy: Another Tool in the Toolbox
od: Anil K. Gehi
Wydane: (2022-12-01)

The genetics of hypertrophic cardiomyopathy: Teare redux.
od: Watkins, H, i wsp.
Wydane: (2008)

HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
od: A. G. Osiev, i wsp.
Wydane: (2016-02-01)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
od: Ariga, R, i wsp.
Wydane: (2018)

Is DNA testing for hypertrophic cardiomyopathy cost-effective?
od: Wordsworth, S, i wsp.
Wydane: (2006)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
od: Watkins, H
Wydane: (2003)

Linked genetic modifiers in hypertrophic cardiomyopathy
od: Ektisham, J, i wsp.
Wydane: (2004)